Skip to main content

Spotfire, Insightful Ink Technology Partnership

NEW YORK, Aug. 24 (GenomeWeb News) - Spotfire and Insightful said today that they have signed an agreement to offer integrated analytics software combining Spotfire's DecisionSite visual analytics with Insightful's advanced S-Plus numerical analytics.

 

According to Spotfire and Insightful, initial applications of the combined technologies are targeted at the companies' large common installed based within the life sciences market. The initial focus of the DecisionSite/S-Plus integration includes applications in drug discovery, pre-clinical, clinical, and post-marketing data analysis and visualization, they added.

 

Specific terms of the arrangement were not disclosed.

 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.